Nucleosides, Nucleotides & Nucleic Acids 2001-01-01

Synthesis of carbocyclic analogs of 2',3'-dideoxysangivamycin, 2',3'-dideoxytoyocamycin, and 2',3'-dideoxytriciribine.

K S Gudmundsson, Z Wang, S M Daluge, P L Feldman

Index: Nucleosides Nucleotides Nucleic Acids 20(10-11) , 1823-30, (2001)

Full Text: HTML

Abstract

Syntheses and antiviral activity of new carbocyclic analogs of 2', 3'-dideoxysangivamycin, 2',3'-dideoxytoyocamycin and 2',3'-dideoxytriciribine is described. The key intermediate, carbocyclic 4-chloro-5-iodopyrrolopyrimidine. was synthesized in good yield via a novel iodination method using I2 and CF3COOAg. This carbocyclic 4-chloro-5-iodopyrrolopyrimidine then allowed for a concise synthesis of the desired 4,5-disubstituted carbocyclic nucleosides.

Related Compounds

  • Sangivamycin
  • Toyocamycin

Related Articles:

Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines.

1998-06-01

[Carbohydr. Res. 308(3-4) , 319-28, (1998)]

Kinetics and localization of the phosphorylation of rhodopsin by protein kinase C.

1995-03-24

[J. Biol. Chem. 270(12) , 6710-7, (1995)]

Synthesis of pyrrolo[2,1-f][1,2,4]triazine C-nucleosides. Isosteres of sangivamycin, tubercidin, and toyocamycin.

2001-03-09

[Carbohydr. Res. 331(1) , 77-82, (2001)]

Shape changes and chemokinesis of Walker carcinosarcoma cells: effects of protein kinase inhibitors (HA-1004, polymyxin B, sangivamycin and tamoxifen) and an inhibitor of diacylglycerol kinase (R 59022).

1993-01-01

[Anticancer Res. 13(2) , 347-54, (1993)]

Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9.

2012-11-01

[Mol. Cancer Ther. 11(11) , 2321-30, (2012)]

More Articles...